D Burger

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Is IL-1 a good therapeutic target in the treatment of arthritis?
    Danielle Burger
    Clinical Immunology Unit, Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Best Pract Res Clin Rheumatol 20:879-96. 2006
  2. ncbi High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals
    Anna Scanu
    Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Arthritis Res Ther 12:R23. 2010
  3. ncbi Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes
    Danielle Burger
    Clinical Immunology Unit Hans Wilsdorf Laboratory, Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    J Immunol 173:1292-7. 2004
  4. ncbi Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis
    Danielle Burger
    Division of Immunology and Allergy, Clinical Immunology Unit Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital and Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
    Proc Natl Acad Sci U S A 106:4355-9. 2009
  5. ncbi High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?
    Danielle Burger
    Division of Immunology and Allergy Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Autoimmun Rev 1:111-7. 2002
  6. ncbi The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes
    D Burger
    Division of Immunology and Allergy, Clinical Immunology Unit Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, CH 1211 Geneva 4, Switzerland
    Rheumatology (Oxford) 42:89-96. 2003
  7. ncbi Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes
    Danielle Burger
    Division of Immunology and Allergy Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, CH 1211 Geneva 14, Switzerland
    Ann N Y Acad Sci 966:464-73. 2002
  8. ncbi The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction
    Danielle Burger
    Division of Immunology and Allergy, Clinical Immunology Unit, University Hospital, Geneva, Switzerland
    Arthritis Res 4:S169-76. 2002
  9. ncbi Cell contact interactions in rheumatology, The Kennedy Institute for Rheumatology, London, UK, 1-2 June 2000
    D Burger
    Clinical Immunology Unit, Division of Immunology and Allergy, University Hospital, Geneva, Switzerland
    Arthritis Res 2:472-6. 2000
  10. ncbi Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I
    J Lou
    Dept of APSIC, University Medical Center, Geneva, Switzerland
    J Neuroimmunol 77:107-15. 1997

Collaborators

Detail Information

Publications38

  1. ncbi Is IL-1 a good therapeutic target in the treatment of arthritis?
    Danielle Burger
    Clinical Immunology Unit, Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Best Pract Res Clin Rheumatol 20:879-96. 2006
    ..Importantly, to be efficacious, anakinra required daily injections, suggesting that administered IL-1Ra displays very short-term effects. Better IL-1 antagonists are in the process of being developed...
  2. ncbi High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals
    Anna Scanu
    Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Arthritis Res Ther 12:R23. 2010
    ....
  3. ncbi Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes
    Danielle Burger
    Clinical Immunology Unit Hans Wilsdorf Laboratory, Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    J Immunol 173:1292-7. 2004
    ..These results demonstrate that CD40L is not required in monocyte activation by direct cellular contact with stimulated T cells, although soluble CD40LT induces the production of TNF in IFN-gamma-macrophages...
  4. ncbi Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis
    Danielle Burger
    Division of Immunology and Allergy, Clinical Immunology Unit Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital and Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
    Proc Natl Acad Sci U S A 106:4355-9. 2009
    ..This study sheds light on a mechanism that is likely to participate in the therapeutic effects of GA in MS...
  5. ncbi High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?
    Danielle Burger
    Division of Immunology and Allergy Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Autoimmun Rev 1:111-7. 2002
    ..e. individuals presenting with risk factors might develop chronic inflammatory diseases after infection. We thus hypothesize that HDL-associated apo A-I might be the missing link between infection and chronic inflammation...
  6. ncbi The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes
    D Burger
    Division of Immunology and Allergy, Clinical Immunology Unit Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, 24 Rue Micheli du Crest, CH 1211 Geneva 4, Switzerland
    Rheumatology (Oxford) 42:89-96. 2003
    ....
  7. ncbi Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes
    Danielle Burger
    Division of Immunology and Allergy Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, CH 1211 Geneva 14, Switzerland
    Ann N Y Acad Sci 966:464-73. 2002
    ..The discrepancy between studies would suggest that the mechanisms are different in physiological and pathophysiological conditions...
  8. ncbi The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction
    Danielle Burger
    Division of Immunology and Allergy, Clinical Immunology Unit, University Hospital, Geneva, Switzerland
    Arthritis Res 4:S169-76. 2002
    ..This review aims to summarize the state of the art and importance of contact-mediated monocyte activation by stimulated TL in cytokine production in rheumatoid arthritis and mechanisms that might control it...
  9. ncbi Cell contact interactions in rheumatology, The Kennedy Institute for Rheumatology, London, UK, 1-2 June 2000
    D Burger
    Clinical Immunology Unit, Division of Immunology and Allergy, University Hospital, Geneva, Switzerland
    Arthritis Res 2:472-6. 2000
    ..Therefore, factors capable of affecting the level of T lymphocyte activation, such as IFN-beta, IL-15 antagonist, or SDF-1alpha antagonist, might be of interest in RA therapy...
  10. ncbi Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I
    J Lou
    Dept of APSIC, University Medical Center, Geneva, Switzerland
    J Neuroimmunol 77:107-15. 1997
    ..These results indicate a therapeutic potential for TBP I in diseases of the central nervous system associated with TNF overproduction...
  11. ncbi Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines
    R Rezzonico
    Division of Immunology and Allergy, Clinical Immunology Unit Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    J Biol Chem 273:18720-8. 1998
    ....
  12. ncbi Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes
    C Chizzolini
    Division of Immunology and Allergy Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    J Immunol 164:5952-60. 2000
    ..This IL-4 activity may be relevant to pathological conditions dominated by Th2 inflammatory responses, resulting in tissue remodeling and destruction...
  13. ncbi Human Th1 cells preferentially induce interleukin (IL)-1beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
    C Chizzolini
    Department of Internal Medicine, Hopital Cantonal Universitaire, Geneva, Switzerland
    Eur J Immunol 27:171-7. 1997
    ..This differential induction of molecules with opposite effects on inflammation stresses the functional heterogeneity in CD4+ T cells...
  14. ncbi Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes
    N Hyka
    Division of Immunology and Allergy (Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, , Switzerland
    Blood 97:2381-9. 2001
    ..The novel anti-inflammatory function of apo A-I reported here might lead to new therapeutic approaches in inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and atherosclerosis...
  15. ncbi IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact
    F Jungo
    Division of Immunology and Allergy, Clinical Immunology Unit (Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    Cytokine 14:272-82. 2001
    ....
  16. ncbi Anti-interleukin-1 therapy in rheumatic diseases
    J M Dayer
    Division of Immunology and Allergy, University Hospital, Geneva, Switzerland
    Curr Opin Rheumatol 13:170-6. 2001
    ....
  17. ncbi Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins
    Anna Scanu
    Division of Immunology and Allergy, Clinical Immunology Unit, Department of Internal Medicine, University Hospital and School of Medicine, Geneva, Switzerland
    J Leukoc Biol 83:921-7. 2008
    ..Furthermore, this study demonstrates that HDL exert an anti-inflammatory effect in nonseptic activation of human monocytes, not only by inhibiting the production of IL-1beta and TNF but also, by leaving sIL-1Ra production unchanged...
  18. ncbi Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
    R Lucas
    Department of Anesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, Geneva, Switzerland
    Eur J Immunol 27:1719-25. 1997
    ..In conclusion, these results indicate that the interaction between membrane TNF and TNFR2 is crucial in the development of this neurological syndrome...
  19. ncbi Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions
    Nicolas Molnarfi
    Division of Immunology and Allergy, Clinical Immunology Unit, Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital and School of Medicine, University of Geneva, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Mol Immunol 45:3419-27. 2008
    ....
  20. ncbi Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes
    Lyssia Gruaz
    Division of Immunology and Allergy, Inflammation and Allergy Research Group, Hans Wilsdorf Laboratory, Department of Internal Medicine and Faculty of Medicine, University of Geneva, Geneva, Switzerland
    PLoS ONE 5:e9418. 2010
    ..High-density lipoproteins (HDL) specifically inhibit the production of pro-inflammatory cytokines induced by T cell contact...
  21. ncbi Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells
    J Lou
    Division of Investigative Anesthesiology, APSIC Department, University Hospital, Geneva, Switzerland
    Eur J Immunol 26:3107-13. 1996
    ..This novel mechanism of inducing the expression of cell adhesion molecules may prompt the initial adhesion of stimulated T lymphocytes to brain endothelium...
  22. ncbi Assays of T-cell contact dependent monocyte-macrophage functions
    Danielle Burger
    Clinical Immunology Unit, University Hospital, Geneva, Switzerland
    Methods Mol Med 136:139-48. 2007
    ..This chapter aims at reviewing and describing the latter methods and strategies...
  23. ncbi Opposite effects of IFN beta on cytokine homeostasis in LPS- and T cell contact-activated human monocytes
    Nicolas Molnarfi
    Division of Immunology and Allergy, Clinical Immunology Unit (Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland
    J Neuroimmunol 146:76-83. 2004
    ..This study demonstrates that IFNbeta displays opposite effects depending on the type of activation of human monocytes, suggesting that it may affect different pathogenic mechanisms in opposite ways...
  24. ncbi From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?
    Jean Michel Dayer
    University Hospital and Faculty of Medicine, 24, Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Expert Opin Biol Ther 5:S83-96. 2005
    ..This review examines the different therapeutic approaches that may be considered for the treatment of immuno-inflammatory diseases, and discusses the advantages and disadvantages of targeting extracellular or intracellular mechanisms...
  25. ncbi Cell-cell interactions and tissue damage in rheumatoid arthritis
    J M Dayer
    Service of Immunology and Allergy, University Hospital, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland
    Autoimmun Rev 3:S14-6. 2004
  26. ncbi Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts
    S Fineschi
    Immunology and Allergy, Department of Internal Medicine, University Hospital and School of Medicine, Geneva, Switzerland
    Rheumatology (Oxford) 46:1779-85. 2007
    ..We aimed to assess the effect of AFA on extracellular matrix (ECM) turnover and whether AFA were associated with anti-topoisomerase-I antibody...
  27. ncbi The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1
    Nicolas Molnarfi
    Division of Immunology and Allergy, Clinical Immunology Unit, Faculty of Medicine, University Hospital, Geneva, Switzerland
    J Immunol 174:2974-80. 2005
    ..Taken together, the present data demonstrate that the induction of sIL-1Ra transcription and production by IFN-beta in human monocytes involved PI3K, but not STAT1 activation...
  28. ncbi HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production
    Rakel Carpintero
    Hans Wilsdorf Laboratory, Inflammation and Allergy Research Group, Division of Immunology and Allergy, Department of Internal Medicine, Faculty of Medicine and University Hospital, University of Geneva, Geneva, Switzerland
    PLoS ONE 5:e11869. 2010
    ..We previously demonstrated that high-density lipoproteins (HDL) inhibited T cell contact- and MPT-induced production of IL-1beta but not of its natural inhibitor, the secreted form of IL-1 receptor antagonist (sIL-1Ra)...
  29. ncbi T cell contact-mediated activation of respiratory burst in human polymorphonuclear leukocytes is inhibited by high-density lipoproteins and involves CD18
    Philippe Cettour-Rose
    Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland
    J Leukoc Biol 77:52-8. 2005
    ..The present results emphasize the importance of direct cell-cell contact with stimulated T cells in inflammatory processes...
  30. ncbi The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes
    Gaby Palmer
    Division of Rheumatology, University Hospital, and Department of Pathology, University of Geneva School of Medicine, Geneva, Switzerland
    Arthritis Res Ther 6:R181-9. 2004
    ..The effect of A77 1726 may be partially mediated by inhibition of COX-2, but other mechanisms likely concur to stimulate IL-1Ra production...
  31. ncbi Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation
    Cristiana E Juge-Aubry
    Endocrine Unit, Division of Endocrinology, Diabetes and Nutrition, Department of Internal Medicine, University Hospital Geneva, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Diabetes 52:1104-10. 2003
    ....
  32. ncbi Glatiramer acetate triggers PI3K?/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes
    Rakel Carpintero
    Division of Immunology and Allergy, Hans Wilsdorf Laboratory, Inflammation and Allergy Research Group, Department of Internal Medicine, University Hospital and Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
    Proc Natl Acad Sci U S A 107:17692-7. 2010
    ..Together, our findings demonstrate the existence of signal transduction triggered by GA, further highlighting the mechanisms of action of this drug in MS...
  33. ncbi Opposite regulation of IL-1beta and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells
    Nicolas Molnarfi
    Division of Immunology and Allergy, Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, University Hospital, Geneva, Switzerland
    J Immunol 178:446-54. 2007
    ....
  34. ncbi Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue
    Cristiana E Juge-Aubry
    Endocrine Unit, Department of Internal Medicine, University Hospital, CH 1211 Geneva 14, Switzerland
    J Clin Endocrinol Metab 89:2652-8. 2004
    ..Finally, human WAT actively secretes these regulatory cytokines, suggesting that they up-regulate IL-1Ra through a local autocrine/paracrine action, which is hypothesized to play a regulatory role in adipogenesis and metabolism...
  35. ncbi A novel MEK2/PI3K? pathway controls the expression of IL-1 receptor antagonist in IFN-?-activated human monocytes
    Karim J Brandt
    Division of Immunology and Allergy, Inflammation and Allergy Research Group, Hans Wilsdorf Laboratory, Department of Internal Medicine, University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Leukoc Biol 88:1191-200. 2010
    ....
  36. ncbi Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease
    Nicolas Vuilleumier
    Division of Immunology and Allergy and Department of Internal Medicine, Geneva University Hospital, 24 Micheli-du-Crest, 1211 Geneva 14, Switzerland
    J Autoimmun 23:353-60. 2004
    ..76, P=0.0066) and anti-Apo A-1 IgG titre in ACS patients. The presence of anti-Apo A-1 autoantibodies in patients with ACS highlights an additional link between autoimmunity, inflammation and atherosclerosis...
  37. ncbi Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation
    Catherine Chenaud
    Division of Surgical Intensive Care, Department of Anesthesiology, Pharmacology, and Surgical Intensive Care, University of Geneva Hospitals, Geneva, Switzerland
    Crit Care Med 32:632-7. 2004
    ..84 [69-94] mg/dL, p =.028). CONCLUSION: A low serum level of apolipoprotein A-I at ICU admission is associated with an increase of the number of SIRS criteria during the ICU stay...
  38. ncbi Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
    Barry Bresnihan
    Department of Rheumatology, St Vincents University Hospital, Dublin, Ireland
    Arthritis Res Ther 6:R563-6. 2004
    ....